Sacral Nerve Stimulation Market Size, Share, Growth 2022-28

The global sacral nerve stimulation market size was valued at USD 2,167.3 million in 2021 and is expected to grow at a CAGR of 12.7% during the forecast period 2022 to 2028. Sacral nerve stimulation (SNS) is a therapeutic technique used to treat bladder and bowel problems, such as overactive bladder, fecal incontinence, and bowel management. It helps restore normal bladder or bowel function and is gaining popularity worldwide with the goal of improving coordination between the bladder or bowel and the brain. The growth of the market is primarily driven by the increase in the elderly population and the incidence of neurological disorders. Additionally, market players' research and development investments in sacral nerve stimulation have propelled market growth. However, health risks associated with sacral nerve stimulation and unfavorable reimbursement policies are hindering market growth. Conversely, untapped regions with unmet medical needs and technological advancements in sacral nerve stimulation to reduce associated infections present profitable opportunities for market growth.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/sacral-nerve-stimulation-market/

Sacral Nerve Stimulation Market Growth Factors:
Urinary incontinence is a prevalent condition in the United States, affecting around 20 million adult Americans, with a higher incidence in women (75-85%). Globally, approximately 200 million individuals experience urinary incontinence. Women over 55 are more susceptible to this condition, which is twice as common in women than men. Incontinence is especially common among the elderly, with over 50% of older adults in the US struggling with it. With a growing elderly population in the US (over 45 million aged 65 and older), and the projected increase to almost 90 million by 2050, the demand for Sacral Nerve Stimulation devices is expected to rise to cater to the increasing number of urinary incontinence cases.

Dementia patients often suffer from urinary incontinence. The Alzheimer's Disease Association estimates that there are currently 45.7 million people living with dementia worldwide, and this number is expected to double every 25 years, reaching 75.5 million by 2030 and 130.5 million by 2050. This is anticipated to lead to an increase in demand for Sacral Nerve Stimulation devices. In the US, according to CDC estimates, there are approximately 5.6 million individuals aged 65 and older with Alzheimer's disease and related dementias, with this number predicted to rise to 15 million by 2060.

Sacral Nerve Stimulation Market Segmentation:
1) Product Type: Implantable SNS, External SNS
2) Technology: Electrical Muscle Stimulation, Transcutaneous Electrical Nerve Stimulation. 3)By Application: Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, Others
4) End-User: Hospitals, Ambulatory Surgical Centers, Others.

Request Sample: https://precisionbusinessinsights.com/request-sample?product_id=56651

Sacral Nerve Stimulation Market Regional Analysis:
The sacral nerve stimulation market is expected to witness a strong growth rate in North America, which currently holds the leading position. This growth can be attributed to several factors such as the rising awareness regarding the treatment options available for conditions like overactive bladder (OAB) and urge incontinence, along with the presence of well-established healthcare facilities in the region. The rapid adoption of technologically advanced medical products, including implantable SNS devices, is also expected to contribute to the growth of the market in this region. Additionally, the availability of increasing reimbursements for innovative devices and treatment procedures is playing a positive role in driving the sacral nerve stimulation market's growth in North America.

The global sacral nerve stimulation market key players are Axonics Modulation Technologies Inc., Biomedical Life Systems Inc., Boston Scientific Corporation, EnteroMedics Inc., Inspire Medical Systems Inc., Johnson and Johnson, Kegel8 (Savantini Limited), Laborie Inc., LivaNova PLC, Medtronic PLC, NeuroPace Inc.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.